Our Feel-Good War on Breast Cancer

“Our Feel-Good War on Breast Cancer.” By Peggy Orenstein, The New York Times Magazine.

I used to believe that a mammogram saved my life. I even wrote that in the pages of this magazine. It was 1996, and I had just turned 35 when my doctor sent me for an initial screening — a . . . → Read More: Our Feel-Good War on Breast Cancer

Every silver lining has a cloud

Much of my life revolves around cancer, both professionally and personally. My ongoing research of breast cancer culture and industry that started over a decade ago entails an immersion into the topic that involves incessant reading of medical studies, news articles, advocacy materials, public policies, and personal stories as well as systematic observation, interviewing, writing, . . . → Read More: Every silver lining has a cloud

Research Brief --

Dr. Patricia Steeg

Patricia S. Steeg, chief of the Center for Cancer Research at the National Cancer Institute, argues in Nature [2012, 485, S58a] that most people with breast cancer die as a result of metastases (spread). Clinical trials, however, are only designed to evaluate a drug’s ability to shrink established tumors rather . . . → Read More: Research Brief — “The Right Trials”

A Conversation with Dr. Patricia Steeg on Redesigning Clinical Trials to Test Therapies that Could Prevent Cancer Metastasis

“A Conversation with Dr. Patricia Steeg on Redesigning Clinical Trials to Test Therapies that Could Prevent Cancer Metastasis” National Cancer Institute Cancer Bulletin

In a perspective published May 30 in Nature, Dr. Patricia Steeg argues that the current system for clinical trials must be redesigned if there is to be a decline in breast cancer . . . → Read More: A Conversation with Dr. Patricia Steeg on Redesigning Clinical Trials to Test Therapies that Could Prevent Cancer Metastasis